| Old Articles: <Older 47281-47290 Newer> |
|---|
 |
The Motley Fool
February 22, 2011
Anders Bylund |
Blue Skies Ahead for Blue Coat? Short-term shortfalls often create long-term opportunity.   |
The Motley Fool
February 22, 2011
Matt Koppenheffer |
Dr. Doom Gets Bullish? Nouriel "Dr. Doom" Roubini looks like he's getting bullish on the stock market. |
The Motley Fool
February 22, 2011
Anders Bylund |
This Stock Is Going to Zero, No Matter What Blockbuster's Hail Mary may save its life, but it won't help shareholders at all. |
The Motley Fool
February 22, 2011
Chuck Saletta |
When Will This Stock Be Worth Buying? Be ready whenever the market gives you the opportunity. |
The Motley Fool
February 22, 2011
Brian Orelli |
Timber! Clinical Data Falls. Forest Labs cuts down Clinical Data. Clinical Data announced today that it agreed to be purchased by Forest Labs for $30 per share. |
The Motley Fool
February 22, 2011
Brian Orelli |
A Billion-Dollar Market to Open "Very Soon" Biosimilar drugs are finally coming to the U.S. |
The Motley Fool
February 22, 2011
Luke Timmerman |
Gilead Buys Calistoga Pharma, Making Move Into Cancer Drugs Gilead diversifies with Calistoga purchase. |
The Motley Fool
February 22, 2011
Jordan DiPietro |
Should You Buy and Hold Home Depot? Does this company have the traits of a good retirement stock? |
The Motley Fool
February 22, 2011
Travis Hoium |
Turning a Light on Utilities Utilities stocks may be ready to rise as the economy picks up and demand improves. |
The Motley Fool
February 22, 2011
Jordan DiPietro |
Rising Star Buy: Range Resources This company is poised to profit when natural gas prices recover. |
| <Older 47281-47290 Newer> Return to current articles. |
